CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 114 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $108 | -99.9% | 986,072 | -0.2% | 0.00% | – |
| Q3 2022 | $163,000 | -34.5% | 988,419 | 0.0% | 0.00% | – |
| Q2 2022 | $249,000 | -56.0% | 988,419 | -7.3% | 0.00% | – |
| Q1 2022 | $566,000 | -34.0% | 1,066,781 | -23.5% | 0.00% | – |
| Q4 2021 | $858,000 | -39.3% | 1,393,897 | +0.6% | 0.00% | – |
| Q3 2021 | $1,413,000 | -43.1% | 1,386,108 | +2.1% | 0.00% | – |
| Q2 2021 | $2,484,000 | -21.5% | 1,357,449 | -15.6% | 0.00% | – |
| Q1 2021 | $3,166,000 | +81.1% | 1,607,521 | +14.9% | 0.00% | – |
| Q4 2020 | $1,748,000 | -23.2% | 1,398,790 | +10.7% | 0.00% | – |
| Q3 2020 | $2,275,000 | -71.3% | 1,263,982 | +33.8% | 0.00% | -100.0% |
| Q2 2020 | $7,922,000 | +52.6% | 944,369 | -4.7% | 0.00% | +100.0% |
| Q1 2020 | $5,190,000 | -39.1% | 990,587 | -36.5% | 0.00% | 0.0% |
| Q4 2019 | $8,516,000 | +134.3% | 1,559,910 | +109.0% | 0.00% | 0.0% |
| Q3 2019 | $3,634,000 | -24.6% | 746,212 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $4,821,000 | +9.8% | 695,675 | +10.1% | 0.00% | 0.0% |
| Q1 2019 | $4,391,000 | -30.7% | 631,874 | -41.8% | 0.00% | 0.0% |
| Q4 2018 | $6,338,000 | +63.3% | 1,085,444 | +111.1% | 0.00% | 0.0% |
| Q3 2018 | $3,881,000 | +55.9% | 514,140 | +4.3% | 0.00% | 0.0% |
| Q2 2018 | $2,490,000 | -1.3% | 493,070 | +19.2% | 0.00% | 0.0% |
| Q1 2018 | $2,524,000 | -13.1% | 413,811 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $2,905,000 | +9.4% | 409,365 | +10.2% | 0.00% | 0.0% |
| Q3 2017 | $2,655,000 | +49.0% | 371,371 | +31.3% | 0.00% | 0.0% |
| Q2 2017 | $1,782,000 | +7.4% | 282,862 | +40.6% | 0.00% | 0.0% |
| Q1 2017 | $1,659,000 | +13.7% | 201,177 | +16.5% | 0.00% | 0.0% |
| Q4 2016 | $1,459,000 | +24.8% | 172,685 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,169,000 | +172.5% | 172,201 | +19.9% | 0.00% | – |
| Q2 2016 | $429,000 | +160.0% | 143,582 | +57.4% | 0.00% | – |
| Q1 2016 | $165,000 | +10.0% | 91,235 | 0.0% | 0.00% | – |
| Q4 2015 | $150,000 | +4.9% | 91,235 | 0.0% | 0.00% | – |
| Q3 2015 | $143,000 | – | 91,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |